Status:
COMPLETED
CopenHeartRFA - Integrated Rehabilitation of Patients Treated for Atrial Fibrillation With Radio Frequency Ablation
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Copenhagen Trial Unit, Center for Clinical Intervention Research
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Atrial fibrillation is the most common arrhythmia and affect 1-2 % of the population in the western world. Atrial fibrillation can be treated with a relatively new procedure, called radiofrequency abl...
Detailed Description
1-2 % of the population in the western world live with atrial fibrillation. One way to treat atrial fibrillation is with radiofrequency ablation. Ablation is a relatively new treatment and therefore o...
Eligibility Criteria
Inclusion
- Patients:
- treated for atrial fibrillation with radiofrequency ablation on Rigshospitalet, Denmark
- 18 years or older
- speaking and understanding Danish
- providing written informed consent
Exclusion
- unable to understand study instructions
- who are pregnant or breastfeeding
- with considerable illness in the musculoskeletal system or with physical disability, which complicates exercise training
- who does strenuous physical training several times a week on competition level
- who does not wish to participate
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01523145
Start Date
December 1 2011
End Date
January 1 2016
Last Update
April 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Copenhagen, Denmark, 2100